| No | TR-020 | 80-08-0 | 4,4'-Sulfonyldianiline (Dapsone) | Mice | B6C3F1 | Female | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | No | TR-020 | 80-08-0 | 4,4'-Sulfonyldianiline (Dapsone) | Mice | B6C3F1 | Male | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | No | TR-020 | 80-08-0 | 4,4'-Sulfonyldianiline (Dapsone) | Rats | F344/N | Female | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | Yes | TR-020 | 80-08-0 | 4,4'-Sulfonyldianiline (Dapsone) | Rats | F344/N | Male | Dosed-Feed | Spleen | Positive | Positive | (FIBROMA, FIBROSARCOMA, SARCOMA) | Neoplastic Lesions | 
                                    
                        | No | TR-130 | 142-04-1 | Aniline hydrochloride | Mice | B6C3F1 | Female | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | No | TR-130 | 142-04-1 | Aniline hydrochloride | Mice | B6C3F1 | Male | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | Yes | TR-130 | 142-04-1 | Aniline hydrochloride | Rats | F344/N | Female | Dosed-Feed | Spleen | Positive | Positive | SARCOMA | Neoplastic Lesions | 
                                    
                        | No | TR-130 | 142-04-1 | Aniline hydrochloride | Rats | F344/N | Male | Dosed-Feed | Vascular System (Spleen) | Positive | Positive | HEMANGIOSARCOMA; SARCOMA OR FIBROSARCOMA | Neoplastic Lesions | 
                                    
                        | No | TR-154 | 103-33-3 | Azobenzene | Mice | B6C3F1 | Female | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | No | TR-154 | 103-33-3 | Azobenzene | Mice | B6C3F1 | Male | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | Yes | TR-154 | 103-33-3 | Azobenzene | Rats | F344/N | Female | Dosed-Feed | Spleen | Positive | Positive | (FIBROSARCOMA) | Neoplastic Lesions | 
                                    
                        | Yes | TR-154 | 103-33-3 | Azobenzene | Rats | F344/N | Male | Dosed-Feed | Spleen | Positive | Positive | (SARCOMA, FIBROSARCOMA) | Neoplastic Lesions | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Rats | F344/N | Male | Inhalation | Kidney Tubular Cell | Clear Evidence | Clear Evidence | renal tubule, adenoma or carcinoma (2/50, 5/50, 8/50, 7/50) | Neoplastic Lesions | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Mice | B6C3F1/N | Female | Inhalation | Liver | Clear Evidence | Clear Evidence | adenoma (18/50, 23/50, 27/50, 29/50);  adenoma or carcinoma (25/50, 26/50, 29/50, 36/50) | Neoplastic Lesions | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Mice | B6C3F1/N | Female | Inhalation | Lung | Clear Evidence | Clear Evidence | alveolar/bronchiolar adenoma (1/50, 26/50, 36/50, 38/50); alveolar/bronchiolar carcinoma (3/50, 16/50, 20/50, 34/50); alveolar/bronchiolar adenoma or carcinoma (4/50, 31/50, 42/50, 46/50) | Neoplastic Lesions | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Mice | B6C3F1/N | Male | Inhalation | Lung | Clear Evidence | Clear Evidence | alveolar/bronchiolar adenoma (13/50, 31/50, 31/50, 29/50); alveolar/bronchiolar carcinoma (9/50, 19/50, 32/50, 33/50); alveolar/bronchiolar adenoma or carcinoma (19/50, 38/50, 42/50, 43/50) | Neoplastic Lesions | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Rats | F344/N | Male | Inhalation | Nasal Cavity | Clear Evidence | Clear Evidence | respiratory epithelium, adenoma (0/50, 7/50, 18/49, 10/50) | Neoplastic Lesions | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Rats | F344/N | Female | Inhalation | Nasal Cavity | Some Evidence | Some Evidence | respiratory epithelium, adenoma (0/50, 5/48, 4/50, 3/50) | Neoplastic Lesions | 
                                    
                        | Yes | TR-542 | 98-82-8 | Cumene | Mice | B6C3F1/N | Male | Inhalation | Spleen | Clear Evidence | Equivocal Evidence | hemangioscaroma | May Have Been Related | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Rats | F344/N | Male | Inhalation | Testis | Clear Evidence | Equivocal Evidence | interstitial cell adenoma | May Have Been Related | 
                                    
                        | No | TR-542 | 98-82-8 | Cumene | Mice | B6C3F1/N | Male | Inhalation | Thyroid Gland Follicular Cell | Clear Evidence | Equivocal Evidence | adenoma | May Have Been Related | 
                                    
                        | No | TR-225 | 5160-02-1 | D&C Red No. 9 | Mice | B6C3F1 | Female | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | No | TR-225 | 5160-02-1 | D&C Red No. 9 | Mice | B6C3F1 | Male | Dosed-Feed | Unspecified | Negative |  | Not applicable | Not applicable | 
                                    
                        | No | TR-225 | 5160-02-1 | D&C Red No. 9 | Rats | F344/N | Female | Dosed-Feed | Liver | Equivocal Evidence | Equivocal | NEOPLASTIC NODULE 1/50 1/50 5/50 | Neoplastic Lesions | 
                                    
                        | No | TR-225 | 5160-02-1 | D&C Red No. 9 | Rats | F344/N | Male | Dosed-Feed | Liver | Positive | Positive | NEOPLASTIC NODULE 0/50 6/50 7/49 | Neoplastic Lesions | 
                                    
                        | Yes | TR-225 | 5160-02-1 | D&C Red No. 9 | Rats | F344/N | Male | Dosed-Feed | Spleen | Positive | Positive | SARCOMA 0/50 0/50 26/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 64-17-5 | Ethanol | Mice | MV | Female | Dosed-Water | Unspecified | Inadequate Study |  | Not applicable | Not applicable | 
                                    
                        | No | TR-510 | 64-17-5 | Ethanol | Mice | MV | Male | Dosed-Water | Unspecified | Inadequate Study |  | Not applicable | Not applicable | 
                                    
                        | No | TR-360 | 121-69-7 | N,N-Dimethylaniline | Mice | B6C3F1 | Male | Gavage | Unspecified | No Evidence |  | Not applicable | Not applicable | 
                                    
                        | No | TR-360 | 121-69-7 | N,N-Dimethylaniline | Rats | F344/N | Female | Gavage | Unspecified | No Evidence |  | Not applicable | Not applicable | 
                                    
                        | No | TR-360 | 121-69-7 | N,N-Dimethylaniline | Mice | B6C3F1 | Female | Gavage | Forestomach | Equivocal Evidence | Equivocal Evidence | SQUAMOUS CELL PAPILLOMA 2/50 2/50 8/50 | Neoplastic Lesions | 
                                    
                        | Yes | TR-360 | 121-69-7 | N,N-Dimethylaniline | Rats | F344/N | Male | Gavage | Spleen | Some Evidence | Some Evidence | SARCOMA 0/49 0/49 3/50 OR OSTEOSARCOMA 0/49 0/49 1/50 COMBINED 0/49 0/49 4/50 | Neoplastic Lesions | 
                                    
                        | No | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Mice | B6C3F1 | Female | Dosed-Feed | Liver | Positive | Positive | (ADENOMA OR CARCINOMA) | Neoplastic Lesions | 
                                    
                        | No | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Rats | F344/N | Female | Dosed-Feed | Mammary Gland | Positive | Positive | (ADENOMA OR FIBROADENOMA) | Neoplastic Lesions | 
                                    
                        | No | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Rats | F344/N | Male | Dosed-Feed | Mesothelium (Abdominal Cavity/Tunica Vaginalis) | Positive | Positive | MESOTHELIOMA | Neoplastic Lesions | 
                                    
                        | Yes | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Rats | F344/N | Female | Dosed-Feed | Spleen | Positive | Positive | (SARCOMA) | Neoplastic Lesions | 
                                    
                        | Yes | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Rats | F344/N | Male | Dosed-Feed | Spleen | Positive | Positive | (SARCOMA) | Neoplastic Lesions | 
                                    
                        | No | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Rats | F344/N | Male | Dosed-Feed | Subcutaneous Tissue | Positive | Positive | (FIBROMA) | Neoplastic Lesions | 
                                    
                        | No | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Rats | F344/N | Female | Dosed-Feed | Urinary Bladder | Positive | Positive | (TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions | 
                                    
                        | No | TR-153 | 636-21-5 | o-Toluidine hydrochloride | Mice | B6C3F1 | Male | Dosed-Feed | Vascular System (Unspecified) | Positive | Positive | HEMANGIOSARCOMA | Neoplastic Lesions | 
                                    
                        | No | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Mice | B6C3F1 | Female | Gavage | Unspecified | No Evidence |  | Not applicable | Not applicable | 
                                    
                        | No | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Rats | F344/N | Male | Gavage | Adrenal Gland Medulla | Clear Evidence | Equivocal Evidence | PHEOCHROMOCYTOMA 13/49 14/48 15/48 26/49 | May Have Been Related | 
                                    
                        | No | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Rats | F344/N | Female | Gavage | Adrenal Gland Medulla | Equivocal Evidence | Equivocal Evidence | PHEOCHROMOCYTOMA 2/50 3/50 1/50 6/50 | Neoplastic Lesions | 
                                    
                        | No | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Mice | B6C3F1 | Male | Gavage | Liver | Some Evidence | Some Evidence | ADENOMA 9/50 15/49 10/50 44/50 OR CARCINOMA 3/50 7/49 11/50 17/50 COMBINED 11/50 21/49 20/50 21/50 | Neoplastic Lesions | 
                                    
                        | Yes | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Rats | F344/N | Male | Gavage | Spleen | Clear Evidence | Clear Evidence | FIBROSARCOMA 0/49 1/50 2/50 17/50, HEMANGIOSARCOMA 0/49 0/50 0/50 4/50, OR OSTEOSARCOMA 0/49 0/50 1/50 19/50 COMBINED 0/49 1/50 3/50 38/50 | Neoplastic Lesions | 
                                    
                        | No | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Rats | F344/N | Female | Gavage | Spleen | Equivocal Evidence | Equivocal Evidence | FIBROSARCOMA 0/50 0/50 1/50 0/50 OR OSTEOSARCOMA 0/50 0/50 0/50 1/50 COMBINED 0/50 0/50 1/50 1/50 | Neoplastic Lesions | 
                                    
                        | No | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Mice | B6C3F1 | Male | Gavage | Vascular System (Liver) | Some Evidence | Some Evidence | HEMANGIOSARCOMA 2/50 2/50 1/49 6/50 | Neoplastic Lesions | 
                                    
                        | No | TR-351 | 20265-96-7 | p-Chloroaniline hydrochloride | Mice | B6C3F1 | Male | Gavage | Vascular System (Spleen) | Some Evidence | Some Evidence | HEMANGIOSARCOMA 3/50 2/47 0/49 5/49 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Male | Dosed-Water | Forestomach | Clear Evidence | Clear Evidence | SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA 0/46 2/47 3/44 5/45 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Harderian Gland | Clear Evidence | Clear Evidence | ADENOMA 3/48 10/48 8/48 21/48 CARCINOMA 0/48 1/48 11/48 11/48 COMBINED 3/48 11/48 19/48 30/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Male | Dosed-Water | Harderian Gland | Clear Evidence | Clear Evidence | ADENOMA 3/47 11/47 25/47 28/47 CARCINOMA 0/47 1/47 7/47 16/47 COMBINED 3/47 12/47 30/47 38/47 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Male | Dosed-Water | Heart | Clear Evidence | Clear Evidence | HEMANGIOSARCOMA 0/48 0/48 1/47 5/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Liver | Clear Evidence | Clear Evidence | HEMANGIOSARCOMA 0/48 0/47 1/47 7/47 ADENOMA 5/48 10/47 19/47 18/47 ADENOMA OR CARCINOMA 5/48 11/47 20/47 19/47 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Male | Dosed-Water | Liver | Clear Evidence | Clear Evidence | HEMANGIOSARCOMA 1/46 2/47 5/46 13/44 ADENOMA 7/46 13/47 17/46 17/44 ADENOMA OR CARCINOMA 12/46 18/47 24/46 23/44 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Lung | Clear Evidence | Clear Evidence | ALVEOLAR/BRONCHIOLAR ADENOMA 4/48 6/48 17/48 29/47 ALVEOLAR/BRONCHIOLAR CARCINOMA 2/48 4/48 13/48 19/47 COMBINED 6/48 8/48 28/48 39/47 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Male | Dosed-Water | Lung | Clear Evidence | Clear Evidence | ALVEOLAR/BRONCHIOLAR ADENOMA 4/48 17/48 22/47 34/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 1/48 1/48 9/47 9/48 COMBINED 5/48 18/48 29/47 37/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Mammary Gland | Clear Evidence | Clear Evidence | ADENOACANTHOMA 0/47 1/46 1/46 11/48 ADENOCARCINOMA 4/47 3/46 3/46 11/48 COMBINED 4/47 4/46 4/46 22/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Ovary | Clear Evidence | Clear Evidence | BENIGN GRANULOSA CELL TUMOR 0/48 0/46 2/46 3/39 MALIGNANT GRANULOSA CELL TUMOR 0/48 0/46 0/46 3/39 COMBINED 0/48 0/46 2/46 5/39 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Skin | Clear Evidence | Clear Evidence | HEMANGIOSARCOMA 0/48 0/48 0/46 2/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Male | Dosed-Water | Skin | Clear Evidence | Clear Evidence | SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA (0/47, 1/48, 5/47, 8/48) | Neoplastic Lesions | 
                                    
                        | Yes | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Spleen | Clear Evidence | Clear Evidence | HEMANGIOSARCOMA 0/48 0/45 1/47 4/46 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | 51-79-6 | Urethane | Mice | MV | Female | Dosed-Water | Uterus/Cervix | Clear Evidence | Clear Evidence | HEMANGIOSARCOMA 0/48 0/47 0/48 2/46 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Harderian Gland | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) ADENOMA 4/48 7/48 6/46 20/46 CARCINOMA 1/48 11/48 7/46 10/46 COMBINED 5/48 18/48 13/46 29/46 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Harderian Gland | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) ADENOMA 2/47 3/47 9/46 19/47 CARCINOMA 1/47 3/47 6/46 16/47 COMBINED 3/47 5/47 15/46 35/47 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Harderian Gland | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) ADENOMA 6/48 14/48 21/47 27/48 CARCINOMA 0/48 0/48 1/47 16/48 COMBINED 6/48 14/48 21/47 38/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Harderian Gland | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) ADENOMA 5/47 12/48 15/48 26/45 CARCINOMA 0/47 2/48 2/48 10/45 COMBINED 5/47 14/48 17/48 35/45 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Heart | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/47 0/47 0/48 3/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Heart | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 0/47 0/48 0/48 6/47 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Heart | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 0/47 0/48 1/48 4/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Heart | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/48 0/48 2/47 4/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Liver | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 1/47 2/47 0/47 7/46 ADENOMA 6/47 5/47 15/47 23/46 ADENOMA OR CARCINOMA 7/47 5/47 16/47 23/46 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Liver | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 0/48 0/47 0/48 6/48 ADENOMA 3/48 6/47 16/48 16/48 ADENOMA OR CARCINOMA 3/48 7/47 16/48 17/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Liver | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 2/48 2/46 4/48 13/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Liver | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 3/47 4/48 3/46 11/48 ADENOMA 12/47 15/48 16/46 24/48 ADENOMA OR CARCINOMA 16/47 19/48 17/46 24/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Lung | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADEMONA 5/48 10/48 18/48 30/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 1/48 7/48 9/48 23/48 COMBINED 5/48 17/48 24/48 37/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Lung | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADENOMA 5/47 10/47 16/48 28/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 0/47 2/47 6/48 23/48 COMBINED 5/47 11/47 21/48 38/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Lung | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADEMONA 6/48 8/48 9/48 33/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 5/48 4/48 5/48 17/48 COMBINED 11/48 11/48 14/48 40/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Lung | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADENOMA 10/48 16/48 19/47 35/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 2/48 3/48 8/47 24/48 COMBINED 11/48 19/48 24/47 43/48 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Mammary Gland | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) ADENOACANTHOMA 0/47 0/48 1/48 9/45 ADENOCARCINOMA 3/47 4/48 6/48 15/45 COMBINED 3/47 4/48 7/48 23/45 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Mammary Gland | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) ADENOACANTHOMA 0/47 0/45 2/48 3/47 ADENOCARCINOMA 4/47 3/45 11/48 14/47 COMBINED 4/47 3/45 12/48 16/47 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Ovary | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) BENIGN GRANULOSA CELL TUMOR 0/46 0/47 5/46 3/45 BENIGN OR MALIGNANT GRANULOSA CELL TUMOR 0/46 0/47 6/46 3/45 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Skin | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/47 0/47 0/48 2/47 | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Skin | Clear Evidence | Clear Evidence | (URETHANE AND 5% ETHANOL) SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA (0/48, 2/47, 0/48, 7/48) | Neoplastic Lesions | 
                                    
                        | No | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Skin | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA (0/48, 1/48, 4/46, 7/47) | Neoplastic Lesions | 
                                    
                        | Yes | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Female | Dosed-Water | Spleen | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/47 0/46 0/46 3/46 | Neoplastic Lesions | 
                                    
                        | Yes | TR-510 | URETHCOMB | Urethane + ethanol (combination) | Mice | MV | Male | Dosed-Water | Spleen | Clear Evidence | Clear Evidence | (URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/46 0/46 1/46 3/46 | Neoplastic Lesions |